Since 2015, over $150 billion has been spent on healthcare mergers and acquisitions, driven by the need for data collaboration in a data-driven economy. This trend, exemplified by CVS's $8 billion acquisition of Signify Health, aims to address challenges in preventative and personalized care, real-world evidence from clinical trials, and genome-wide association studies by integrating disparate data sets. The integration of data allows for actionable insights that improve healthcare delivery and patient outcomes, although it is constrained by privacy regulations, data security requirements, and the fragmented nature of data held by different stakeholders like care providers, insurers, and pharmacies. The ultimate goal of these acquisitions is to facilitate better healthcare accessibility and delivery through trusted partnerships and holistic data analysis, despite the challenges posed by cybersecurity risks and regulatory compliance.